Breaking
Friday, June 19, 2026
🇺🇸 Americas · Directory profile

Humanized mouse models

Humanized Mouse Models CRO

Visit website

Company overview

TransCure bioServices specializes in humanized mouse models and preclinical CRO services for immuno-oncology, infectious diseases, and inflammatory conditions. They offer advanced platforms including flow cytometry, IHC, imaging, in vitro assays, and diverse models such as CDX in humanized mice, conventional strains, and orthotopic tumors. With over 12 years of expertise, they provide flexible, high-quality studies to accelerate pharmaceutical research.

Humanized mouse models is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, CRO & Clinical Services partner serving United States & Americas. Core focus areas include humanized mouse models, immuno-oncology cro, preclinical services, flow cytometry, cdx models.

Industry categories: Life Science Reagents, CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.

Products and technologies associated with Humanized mouse models include Cro, Flow Cytometry — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.

Structured facts

Website
https://www.transcurebioservices.com
Categories
Life Science Reagents, CRO & Clinical Services
Markets served
United States & Americas
Keywords
humanized mouse models, immuno-oncology cro, preclinical services, flow cytometry, cdx models

Products & technologies

  • Cro
  • Flow Cytometry

Therapeutic areas

  • Oncology

Markets served

  • United States & Americas

Industry categories

Company timeline

  1. — Profile published on NovaPharmaNews
  2. — Profile last updated

Related suppliers in category

Frequently asked questions

What types of mouse models does TransCure bioServices offer?
TransCure offers humanized mouse models (CD34+ humanized strains like NCG, NOG), conventional immunocompetent models (C57BL/6, BALB/c), subcutaneous and orthotopic CDX tumor models for immuno-oncology, and disease models for IBD, MASH, asthma, allergy, and lung fibrosis.
What technologies and assays are available?
State-of-the-art platforms include flow cytometry, IHC, imaging, in vitro assays, and CBA-based cytokine profiling for precise, reproducible preclinical results and immune response insights.
What therapeutic areas do they support?
They support oncology (immuno-oncology), infectious diseases, inflammatory conditions including IBD, MASH, asthma, allergy, and lung fibrosis with customizable high-quality studies.